Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Nov. 18, 2020, 5:01 p.m. EST

Corbus Pharmaceuticals Holdings Inc. stock remains steady Wednesday, still outperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Corbus Pharmaceuticals Holdings Inc. CRBP were unchanged Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.82% to 11,801.60 and Dow Jones Industrial Average DJIA falling 1.16% to 29,438.42. Corbus Pharmaceuticals Holdings Inc. closed $8.58 short of its 52-week high ($9.78), which the company reached on August 31st.

The stock outperformed some of its competitors Wednesday, as Fate Therapeutics Inc. FATE fell 5.15% to $49.72, Vanda Pharmaceuticals Inc. VNDA fell 3.25% to $12.82, and Viking Therapeutics Inc. VKTX fell 2.49% to $6.26. Trading volume (3.7 M) remained 1.6 million below its 50-day average volume of 5.3 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.